Not exclusively, the geographic scope varies quite a bit across the 11 programs. Majority of them are EU specific, but there are also some with international scope (G4A, DayOne). My recommendation is to verify the eligibility for the program of interest
I like to see them as being the main validation signals that de-risk the business early-stage and strengthen Founder's negotiating position with strategic investors (when the time comes). Recently I've seen many investors filtering health start-ups based on grants they already accessed, cohorts they are part of or already established partnerships.
Hi just wanted to understand is this grants specific for eu regions or all across
Not exclusively, the geographic scope varies quite a bit across the 11 programs. Majority of them are EU specific, but there are also some with international scope (G4A, DayOne). My recommendation is to verify the eligibility for the program of interest
Sure thanks for the reply :)
Non-dilutive funding options like these are invaluable for health start-ups looking to scale while preserving early equity
I like to see them as being the main validation signals that de-risk the business early-stage and strengthen Founder's negotiating position with strategic investors (when the time comes). Recently I've seen many investors filtering health start-ups based on grants they already accessed, cohorts they are part of or already established partnerships.